Research study Program year 2025 Source: CMS Open Payments

Clarifix Rhinitis Randomized Controlled Trial

Research payments

$971,438

180 payments

Through program year 2025, $971,438 in research payments was reported against Clarifix Rhinitis Randomized Controlled Trial, across 180 payments, paid by Stryker Corporation.

Paid by: Stryker Corporation
ClinicalTrials.gov: No trial number was reported for this study

By program year

3 rows

Year	Kind	Amount	Payments
2025	Research	$3,600	1
2021	Research	$360,153	104
2020	Research	$607,684	75

Breakdown

Who paid Research payments · program years 2020–2025

Stryker Corporation $971,438 180 payments

Who received the money Research payments · program years 2020–2025

ICAHN School of Medicine at Mount Sinai Organisation paid for research $262,522 15 payments
Spokane Ent Organisation paid for research $147,694 19 payments
St Vincent Anderson Hospital Organisation paid for research $111,045 25 payments
Specialty Physician Assoc Organisation paid for research $90,384 9 payments
Ear Nose And Throat Associates Of South Florida PA Organisation paid for research $79,400 16 payments
St Cloud Ent Organisation paid for research $76,213 12 payments
Breathe Clear Institute Organisation paid for research $70,458 20 payments
Specialty Physician Associates Organisation paid for research $28,670 11 payments
Medical Univ Of S Carolina Organisation paid for research $25,360 6 payments
Advarra INC Organisation paid for research $13,125 16 payments

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

10 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.